We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$2.21B
AUM Growth
-$393M
Cap. Flow
-$546M
Cap. Flow %
-24.73%
Top 10 Hldgs %
59.1%
Holding
89
New
17
Increased
7
Reduced
6
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Communication Services 8.85%
3 Healthcare 8.6%
4 Financials 8.02%
5 Industrials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
1
Dell
DELL
$283B
$199M 9%
8,720,847
-1,646,216
-16% -$37.3M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$167M 7.58%
627,300
+60,900
+11% +$15.8M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$158M 7.16%
1,037,400
+757,400
+271% +$114M
NXPI icon
4
NXP Semiconductors
NXPI
$68B
$154M 6.95%
1,311,083
-84,171
-6% -$9.72M
TWX
5
DELISTED
Time Warner Inc
TWX
$150M 6.81%
1,645,000
-2,960,267
-64% -$280M
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$455B
$129M 5.85%
+830,000
New +$127M
HRG
7
DELISTED
HRG Group, Inc.
HRG
$117M 5.32%
6,930,232
-1,137,189
-14% -$18.4M
LH icon
8
Labcorp
LH
$24.3B
$95.7M 4.33%
698,400
SRG
9
Seritage Growth Properties
SRG
$130M
$73M 3.3%
1,803,614
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$62M 2.8%
232,200
-569,800
-71% -$148M
ISBC
11
DELISTED
Investors Bancorp, Inc.
ISBC
$58.3M 2.64%
4,200,000
DD icon
12
DuPont de Nemours
DD
$18.6B
$57M 2.58%
315,905
IWM icon
13
iShares Russell 2000 ETF
IWM
$80.9B
$51.4M 2.33%
337,048
+61,336
+22% +$9.21M
BIIB icon
14
Biogen
BIIB
$29.9B
$47.8M 2.16%
150,000
XRT icon
15
PUT
State Street SPDR S&P Retail ETF
XRT
$365M
$42.2M 1.91%
+933,400
New +$39.2M
LSXMK
16
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$34.8M 1.57%
1,151,493
EVHC
17
DELISTED
Envision Healthcare Holdings Inc
EVHC
$34.6M 1.56%
+1,000,000
New +$35M
TFCFA
18
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$34.5M 1.56%
+1,000,000
New +$29.8M
ENVA icon
19
Enova International
ENVA
$5.91B
$34.5M 1.56%
2,270,788
+83,781
+4% +$1.23M
QCOM icon
20
Qualcomm
QCOM
$176B
$34.1M 1.54%
+533,000
New +$32.3M
MDY icon
21
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$32.9M 1.49%
95,300
+66,400
+230% +$22.4M
LTRPA
22
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$29.2M 1.32%
3,096,032
KRNY icon
23
Kearny Financial
KRNY
$592M
$28.2M 1.27%
1,948,562
TFSL icon
24
TFS Financial
TFSL
$5.1B
$26.7M 1.21%
1,788,868
LSXMA
25
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$22.9M 1.04%
800,031

Similar funds

Empyrean Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Empyrean Capital Partners held 89 positions worth $2.21B, down 15% from $2.6B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Empyrean Capital Partners withdrew a net $546M in Q4 2017, closing 27 positions and reducing 6 holdings. Its most notable exit was Molina Healthcare, an estimated $43.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Empyrean Capital Partners opened a new position in Envision Healthcare Holdings Inc worth $34.6M.

  • Empyrean Capital Partners's largest Q4 2017 buy was Envision Healthcare Holdings Inc: 1,000,000 shares worth $34.6M.
  • Empyrean Capital Partners added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $22.4M increase.
  • Empyrean Capital Partners's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $280M.
  • Empyrean Capital Partners fully exited Molina Healthcare in Q4 2017, selling an estimated $43.1M.
  • Empyrean Capital Partners's ten largest holdings make up 59% of its $2.21B portfolio in Q4 2017.
  • Empyrean Capital Partners opened 17 new positions and closed 27 in Q4 2017.
  • Empyrean Capital Partners's portfolio value fell 15% quarter-over-quarter to $2.21B.

Based on Empyrean Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.